Tiansheng Pharmaceutical Group Co Ltd
002872
Company Profile
Business description
Tiansheng Pharmaceutical Group Co Ltd is a pharmaceutical company. It is engaged in the research, development, production, and sales of pharmaceutical products. The company's business scope covers pharmaceutical manufacturing, circulation, Chinese herbal medicine planting and processing, drug research and development, and others. Its products cover respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, oncology, hepatobiliary, blood, surgery, diabetes and other systems.
Contact
West Street, Agricultural Park
Shipanhe, Yubei District
Chongqing401120
CHNT: +86 2362980139
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,273
Stocks News & Analysis
stocks
Chart of the Week: CGT reform strengthens the case for dividend investing
Why dividend stocks are gaining an edge after tax reform.
stocks
Finding ASX opportunities in lofty market conditions
A widening valuation gap is revealing more discounted ASX shares with moats.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,122.70 | 62.80 | -0.68% |
| CAC 40 | 8,493.10 | 84.83 | 1.01% |
| DAX 40 | 25,528.77 | 68.29 | 0.27% |
| Dow JONES (US) | 51,594.14 | 1,153.18 | -2.19% |
| FTSE 100 | 10,946.37 | 37.96 | 0.35% |
| HKSE | 25,858.88 | 50.96 | 0.20% |
| NASDAQ | 24,442.94 | 433.97 | -1.74% |
| Nikkei 225 | 61,867.43 | 433.24 | 0.71% |
| NZX 50 Index | 13,762.78 | 213.89 | -1.53% |
| S&P 500 | 7,316.15 | 112.63 | -1.52% |
| S&P/ASX 200 | 8,967.70 | 57.10 | -0.63% |
| SSE Composite Index | 3,804.69 | 23.78 | -0.62% |